ESSA Pharma Inc. (EPIX) has 20 既知のインサイダーおよび機関投資家保有者の記録. 最大保有者は BIOTECH GROWTH N V 7,379,583 株保有. その他の主要保有者には BB BIOTECH AG および Parkinson David Ross.
EPIX インサイダー保有状況
最大保有者
BIOTECH GROWTH N V
7,379,583 株
インサイダー上位保有者
| # |
氏名 |
役職 |
保有株数 |
最終申告日 |
相対規模 |
| 1 |
Biotech Growth N V |
Director |
7,379,583 |
2022-10-28 |
|
| 2 |
Bb Biotech Ag |
Director |
5,879,583 |
2022-07-20 |
|
| 3 |
Parkinson David Ross |
Chief Executive Officer |
350,000 |
2024-03-28 |
|
| 4 |
Drapkin Kimberlee C |
Chief Financial Officer |
324,367 |
2009-07-01 |
|
| 5 |
Cesano Alessandra |
Chief Medical Officer |
200,000 |
2024-03-28 |
|
| 6 |
Schor Chen |
Chief Business Officer |
146,235 |
2009-03-03 |
|
| 7 |
Wood David S. |
Chief Financial Officer |
110,000 |
2024-03-28 |
|
| 8 |
Glickman Richard M |
Director |
70,000 |
2024-03-28 |
|
| 9 |
Martin John Alexander |
Director |
50,000 |
2024-03-28 |
|
| 10 |
Thorell Marella |
Director |
50,000 |
2024-03-28 |
|
| 11 |
Sollis Gary |
Director |
50,000 |
2024-03-28 |
|
| 12 |
Zweifach Sanford S |
Director |
50,000 |
2024-03-28 |
|
| 13 |
Berger Franklin M |
Director |
50,000 |
2024-03-28 |
|
| 14 |
Kantoff Philip W. |
Director |
50,000 |
2024-03-28 |
|
| 15 |
Requadt Scott |
Director |
50,000 |
2024-03-28 |
|
| 16 |
Noiman Silvia |
Sr VP Pipeline Mgt, GM Israel |
35,000 |
2006-09-21 |
|
| 17 |
Leuchtenberger Mark |
Director |
25,000 |
2009-06-18 |
|
| 18 |
Merendino Lauren |
Director |
25,000 |
2024-03-28 |
|
| 19 |
Brettman Ari David |
Director |
16,500 |
2021-01-26 |
|
| 20 |
Smith Ian F |
Director |
10,000 |
2009-06-18 |
|
EPIX の保有データがありません。
